Bank of New York Mellon Corp (BNY)
Valuation Overview•Is Bank of New York Mellon Corp Overvalued or Undervalued?
Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Underlying fundamental quality and solvency metrics are in stable range.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Confirm your valuation thesis with live pattern overlays, key pivot levels, and AI trade plans.
Verdict: Highly distressed profile flashing severe fundamental warning signs.
Wall Street is cautious, forecasting potential downside with steady expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
BNY demonstrates adequate business quality with stable profitability. This is backed by a fortress balance sheet, holding significant net cash ($97.6B) and minimal debt risk.
The company is driving exceptional top-line expansion (26.9% 3Y CAGR) paired with highly explosive earnings growth (36.7% EPS 3Y CAGR).
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | +2.2% | +26.9% | +19.5% | +10.6% | |
| EBITDA | $2.6B | — | +19.2% | — | — | |
| Net Income | $1.7B | +22.5% | +29.5% | — | +5.8% | |
| EPS (Diluted) | $2.34 | +27.8% | +36.7% | +14.1% | +10.6% | |
| Free Cash Flow | $5.8B | +762.0% | -27.7% | +6.3% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | — | 48.8% | 65.6% | 77.4% |
| Operating Margin | — | 15.0% | 18.4% | 23.3% |
| Net Margin | — | 11.6% | 14.3% | 18.6% |
| FCF Margin | — | 8.2% | 20.8% | 20.5% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $1.96 | $2.25 | +14.8% | ||
| Q1'26 | $1.91 | $2.02 | +5.8% | ||
| Q4'25 | $1.76 | $1.91 | +8.5% | ||
| Q3'25 | $1.75 | $1.94 | +10.9% | ||
| Q2'25 | $1.50 | $1.58 | +5.3% | ||
| Q1'25 | $1.53 | $1.56 | +2.0% | ||
| Q4'24 | $1.41 | $1.52 | +7.8% | ||
| Q3'24 | $1.42 | $1.51 | +6.3% |
The S&P 500 is at 29.9x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Bank of New York Mellon Corp (BNY) valuation, health, and returns.
Bank of New York Mellon Corp is estimated to be fairly valued under our discounted cash flow framework. relative multiples indicate the stock is Slightly expensive versus peers compared to industry peers. trading near fair value (DCF: $104.37)
Bank of New York Mellon Corp has multiple valuation anchors: DCF Intrinsic Value: $104.37 | Peer Relative Fair Value: $126.19 | Wall Street Analyst Target: $87.00 (implying -39.5% upside). A convergence of these signals offers higher conviction.
Bank of New York Mellon Corp displays n/a financial health with a composite quality score of N/A/100, supported by a Piotroski F-Score of 8/9.
Bank of New York Mellon Corp pays a 1.4% dividend yield, covered by a 26% payout ratio with 15 years of growth, supplemented by a 4.6% buyback yield.
Bank of New York Mellon Corp's current growth trajectory is Decelerating. The company achieved +2.2% 1Y revenue growth and +27.8% 1Y EPS growth, compared to its 3Y revenue CAGR of +26.9%.
Wall Street consensus is Buy based on 29 analysts. The consensus price target represents a -39.5% change from current levels.
No major financial distress warning signs or extreme volatility triggers are flagged at this time.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.